Genmab
GMAB
$19.06
Share price
-1.19%
Change (1 day)
-36.42%
Change (1 year)
Categories
Earnings for Genmab (GMAB)
Earnings in 2024 (TTM): $1.31 Billion USD
According to Genmab's latest financial reports the company's current earnings are $3.10 Billion USD. , an increase over its 2023 earnings that were of $0.80 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Genmab from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | $1.31 B | 63.99% |
| 2023 | $0.80 B | -17.29% |
| 2022 | $0.96 B | 55.87% |
| 2021 | $0.62 B | -31.09% |
| 2020 | $0.90 B | 111.51% |
| 2019 | $0.42 B | 69.44% |
| 2018 | $0.25 B | 49.63% |
| 2017 | $0.16 B | 3.27% |
| 2016 | $0.16 B | 46.33% |
| 2015 | $0.11 B | 117.13% |
| 2014 | $51.28 M | 329.17% |
| 2013 | $11.94 M | -159.26% |
| 2012 | -$20.17 Million | -48.96% |
| 2011 | -$39.51 Million | 90.86% |
| 2010 | -$20.7 Million | -67.46% |
| 2009 | -$63.62 Million |